Evelyne Gicquel

Identifiants chercheurs

IdHAL :

evelyne-gicquel

IdRef :

19795460X

VIAF :

486148704269436931707

Présentation

Publications

Article dans une revue (21)

[Advances and Challenges in Microdystrophin gene therapy for Duchenne Muscular Dystrophy: progress and future directions]. Abbass Jaber,Laura Palmieri,Evelyne Gicquel,Isabelle Richard,David Israeli Médecine/Sciences, 2024, 40, pp.46-51. ⟨10.1051/medsci/2024138⟩ Article dans une revue istex hal-05386305v1
Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa −/− mice P. Sellier,P. Vidal,B. Bertin,E. Gicquel,E Bertil‐froidevauxet al. Journal of Inherited Metabolic Disease, 2023, 47 (1), pp.119-134. ⟨10.1002/jimd.12625⟩ Article dans une revue hal-04795500v1
CRISPR-Cas9 KO Cell Line Generation and Development of a Cell-Based Potency Assay for rAAV-FKRP Gene Therapy Marine Geoffroy,Louna Pili,Valentina Buffa,Maëlle Caroff,Anne Bigotet al. Cells, 2023, 12 (20), pp.2444. ⟨10.3390/cells12202444⟩ Article dans une revue hal-04795434v1
Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy Ai Vu Hong,Nathalie Bourg,Peggy Sanatine,Jerome Poupiot,Karine Chartonet al. Life Science Alliance, 2022, 6 (1), pp.e202201506. ⟨10.26508/lsa.202201506⟩ Article dans une revue hal-04795477v1
Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies Celine Bruge,Marine Geoffroy,Manon Benabides,Emilie Pellier,Evelyne Gicquelet al. Biomedicines, 2022, 10 (6), pp.1428. ⟨10.3390/biomedicines10061428⟩ Article dans une revue hal-03858917v1
Minimal Consequences of CMAH and DBA/2J Background on a FKRP Deficient Model Camille Vaubourg,Evelyne Gicquel,Isabelle Richard,William Lostal,Jessica Bellec Journal of Neuromuscular Diseases, 2021, 8 (5), pp.785-793. ⟨10.3233/JND-200487⟩ Article dans une revue hal-03003866v2
Functional and cellular localization diversity associated with Fukutin-related protein patient genetic variants Sara F Henriques,Evelyne Gicquel,Justine Marsolier,Isabelle Richard Human Mutation, 2019, 40 (10), pp.1874-1885. ⟨10.1002/humu.23827⟩ Article dans une revue hal-02177499v1
γ-sarcoglycan and dystrophin mutation spectrum in an Algerian cohort Evelyne Gicquel,Natacha Maizonnier,Steven Foltz,William Martin,Nathalie Bourget al. Muscle & nerve. Supplement., 2017, 56 (1), pp.129-135. ⟨10.1002/mus.25443⟩ Article dans une revue hal-02333075v1
AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression Evelyne Gicquel,Natacha Maizonnier,Steven Foltz,William Martin,Nathalie Bourget al. Human Molecular Genetics, 2017, 26 (10), pp.1952-1965. ⟨10.1093/hmg/ddx066⟩ Article dans une revue hal-02177575v1
216th ENMC international workshop: Clinical readiness in FKRP related myopathies January 15–17, 2016 Naarden, The Netherlands Isabelle Richard,Jean-Pierre Laurent,Sebahattin Cirak,John Vissing,Susan Brownet al. Neuromuscular Disorders, 2016, 26 (10), pp.717-724. ⟨10.1016/j.nmd.2016.08.012⟩ Article dans une revue hal-02333077v1
Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy Ruthger van Zwieten,Stefania Puttini,Małgorzata Lekka,Guillaume Witz,Evelyne Gicquel-Zouidaet al. Nanomedicine, 2014, 9 (4), pp.393-406. ⟨10.2217/NNM.12.215⟩ Article dans une revue hal-02336895v1
The Phenotype of Dysferlin-Deficient Mice Is Not Rescued by Adeno-Associated Virus–Mediated Transfer of Anoctamin 5 Florence Le Roy,Laurence Suel,Jérôme Poupiot,Marc Bartoli,François Monjaretet al. Human gene therapy. Clinical development, 2013, 24 (2), pp.65-76. ⟨10.1089/humc.2012.217⟩ Article dans une revue hal-02336935v1
A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome. Gaëlle Blandin,Sylvie Marchand,Karine Charton,Nathalie Danièle,Evelyne Gicquelet al. Skeletal Muscle, 2013, 3 (1), pp.3. ⟨10.1186/2044-5040-3-3⟩ Article dans une revue inserm-00805816v1
Rescue of Sarcoglycan Mutations by Inhibition of Endoplasmic Reticulum Quality Control is Associated with Minimal Structural Modifications Tayebeh Soheili,Evelyne Gicquel,Jérôme Poupiot,Luu N'Guyen,Florence Le Royet al. Human Mutation, 2012, 33 (2), pp.429-439. ⟨10.1002/humu.21659⟩ Article dans une revue istex hal-01610024v1
Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies Karine Charton,Nathalie Danièle,Anna Vihola,Carinne Roudaut,Evelyne Gicquelet al. Human Molecular Genetics, 2010, 19 (23), pp.4608-4624. ⟨10.1093/hmg/ddq388⟩ Article dans une revue hal-02321460v1
NF‐NF ‐κ BB‐dependent expression of the antiapoptotic factor c‐FLIP is regulated by calpain 3, the protein involved in limb‐girdle muscular dystrophy type 2A Béatrice Benayoun,Stephen Baghdiguian,Alicia Lajmanovich,Marc Bartoli,Nathalie Danieleet al. FASEB Journal, 2008, 22 (5), pp.1521-1529. ⟨10.1096/fj.07-8701com⟩ Article dans une revue hal-03674309v1
Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. Marc Bartoli,Evelyne Gicquel,Laetitia Barrault,Tayebeh Soheili,Marie Malissenet al. Human Molecular Genetics, 2008, 17 (9), pp.1214-21. ⟨10.1093/hmg/ddn029⟩ Article dans une revue istex hal-00294192v1
NF-kappa B-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A Beatrice Benayoun,Stephen Baghdiguian,Alicia Lajmanovich,Marc Bartoli,Nathalie Danièleet al. FASEB Journal, 2008, 22 (5), pp.1521-1529. ⟨10.1096/fj.07-8701com⟩ Article dans une revue hal-01610041v1
Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector Françoise Fougerousse,Marc Bartoli,Jérôme Poupiot,Ludovic Arandel,Muriel Durandet al. Molecular Therapy, 2007, 15 (1), pp.53-61. ⟨10.1038/sj.mt.6300022⟩ Article dans une revue hal-01610043v1
Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A Marc Bartoli,C Roudaut,S Martin,F Fougerousse,L Suelet al. Molecular Therapy, 2006, 13 (2), pp.250-259. ⟨10.1016/j.ymthe.2005.09.017⟩ Article dans une revue hal-01610047v1
Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints F. Apparailly,M. Khoury,M.J.B. Vervoordeldonk,J. Adriaansen,E. Gicquelet al. Human Gene Therapy, 2005, 16 (4), pp.426-434. ⟨10.1089/hum.2005.16.426⟩ Article dans une revue hal-04942439v1

Communication dans un congrès (1)

Unprecedented low dose of AAV-mediated gene transfer corrects the pathology in a model for Fukutin-Related-Protein deficiencies Evelyne Gicquel,Marine Faivre,Susan Brown,Laurine Buscara,Nathalie Danieleet al. ASGCT 24th Annual Meeting - Session "Metabolic and Muscle Diseases, Tissue and Immunological Engineering", American Society of Gene & Cell Therapy, May 2021, Virtual, France Communication dans un congrès hal-04955718v1

Pré-publication, Document de travail (1)

Transgene-Induced Cardiotoxicity In High-Dose AAV Gene Transfer Ariane Biquand,Evelyne Gicquel,Jérôme Poupiot,Marine Faivre,Stephany Campuzanoet al. 2025 Pré-publication, Document de travail hal-05398539v1